drugset / Trial / NCT05860270
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Phase 4
Recruiting
176 enrolled
Peking University First Hospital
Beijing Anzhen Hospital · collabBeijing Fangshan District Hospital of Traditional Chinese Medicine · collabBeijing Haidian Hospital · collabBeijing Tsinghua Changgeng Hospital · collabCapital Medical University · collabPeking University International Hospital · collabPeking University People's Hospital · collabPeking University Shenzhen Hospital · collabPeking University Third Hospital · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.
Timeline
- Start
- 2023-06-15
- Primary completion
- 2026-03-31
- Completion
- 2026-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cholecalciferol | Other / unclassified | 4000 iu | Oral |